ISRCTN ISRCTN14031168
DOI https://doi.org/10.1186/ISRCTN14031168
ClinicalTrials.gov number NCT00122811
Secondary identifying numbers RG/97010
Submission date
18/11/2001
Registration date
18/11/2001
Last edited
14/11/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Professor CJ Bulpitt
Scientific

Care of the Elderly
Division of Medicine
ICSM at Hammersmith Hospital
Du Cane Road
London
W12 0NN
United Kingdom

Phone +44 (0)20 8383 3959
Email c.bulpitt@ic.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study acronymHYVET
Study objectivesTo assess the benefits of treating very elderly patients with hypertension.
Ethics approval(s)Approved by the relevent central and local ethics committees
Health condition(s) or problem(s) studiedHypertension
InterventionTwo treatment groups:
1. Placebo
2. Indapamide Sustained Release (SR) 1.5 mg plus perindopril 2 - 4 mg if required.

Goal: diastolic blood pressure less than 80 mmHg with systolic pressure less than 150 mmHg.

The patients are followed-up both according to clinical need and every 3 months in the first year and every 6 months thereafter.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Indapamide Sustained Release (SR), perindopril
Primary outcome measureStroke events (fatal and non-fatal).
Secondary outcome measures1. Total mortality
2. Cardiovascular mortality
3. Cardiac mortality
4. Stroke mortality
5. Skeletal fracture
Overall study start date01/01/2001
Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants2100
Key inclusion criteria1. People 80 years old and above
2. Sustained systolic pressure 160 - 199 mmHg and diastolic (phase V) pressure 90 - 109 mmHg
3. No evidence of renal failure or co-morbidity requiring anti-hypertensive treatment
Key exclusion criteriaDoes not comply with above inclusion criteria.
Date of first enrolment01/01/2001
Date of final enrolment31/12/2009

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Care of the Elderly
London
W12 0NN
United Kingdom

Sponsor information

British Heart Foundation (UK)
Charity

14 Fitzhardinge Street
London
W1H 6DH
United Kingdom

Phone +44 (0)20 7935 0185
Email research@bhf.org.uk
Website http://www.bhf.org.uk/
ROR logo "ROR" https://ror.org/02wdwnk04

Funders

Funder type

Charity

British Heart Foundation (UK) (ref: RG/97010)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
the_bhf, The British Heart Foundation, BHF
Location
United Kingdom
Institut de Recherches Internationales Servier (France)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article main trial protocol 01/07/2001 Yes No
Protocol article sub-study protocol 19/12/2006 Yes No
Results article results 01/05/2008 Yes No
Results article results 01/07/2010 Yes No